PubMed Health⌕ Search

Biomedical subjects

M Chopan

Publications and source records attributed to M Chopan.

4 recordsLinked to original sources

The suppression of tumorigenicity in human X mouse cell hybrids. I. Derivation of hybrid clones, chromosome analysis and tumorigenicity studies.

The nature of genetic determinants associated with the regulation of malignancy was investigated in interspecies (human X mouse) cell hybrids. An apparently transformed diploid human cell strain (ME) was fused with a malignant, HGPRT-deficient, mouse cell line (A9). A primary hybrid with an unusual stellate appearance that contained the isozymic forms of lactate dehydrogenase from both parent cells was selected. Through further cloning, four tertiary hybrid cell clones were obtained in which malignancy was substantially inhibited and in which the human chromosome content was reduced or completely absent. Two of the hybrid clones whose malignant phenotype was stably suppressed contained no apparent human chromosomes, whereas the other two, whose phenotype was unstable, contained a part of a human chromosome. Our results are consistent with the view that suppression of malignancy occurs in interspecies hybrids consisting of a malignant mouse and a transformed human parent cell. At present, however, any assignment of a specific human chromosome, or specific fragments thereof, that may suppress the expression of malignancy in these hybrids, is a matter of conjecture.

Adenoma↗

The suppression of tumorigenicity in human X mouse cell hybrids. II. The relationship between tumorigenicity and parameters of transformation in vitro.

We have studied the expression of transformation-related parameters in tertiary hybrid clones from an apparently transformed human cell strain (ME) and a malignant mouse cell line (A9). The derivation of these hybrid clones, chromosome analysis, and tumorigenic potential have been reported elsewhere (1). In the present work, the serum sensitivity, saturation density, cloning efficiency on plastic surfaces and in semisolid medium, survival in aggregate form, concanavalin A agglutinability, sugar uptake, and secretion of plasminogen activator in 4 tertiary hybrid clones and in both parent cells have been determined. While, in general, the extent to which these transformation-related traits were expressed in the hybrid clones closely resembled the malignant A9 parent cell, all hybrids displayed partial to complete suppression of tumorigenicity. These results suggest no apparent relationship between the extent of quality of transformation and tumorigenicity in these cell hybrids.

Agglutination↗

A nontumorigenic (mouse X human) cell hybrid inhibits tumorigenicity of its malignant mouse parent cell and unrelated human tumor cells in vivo.

This report describes the modulation of malignant through coinoculation in vivo of a malignant mouse (A9) cell line, and a phenotypically stable, nontumorigenic hybrid clone derived from it by fusion with a transformed mutant human cell. Thus, the tumorigenicity of the A9 cells was suppressed by the hybrid cells, but not by the unrelated normal cells. The hybrid cells also inhibited tumor development of unrelated human cancer cells.

Animals↗